Skip to main content

Cancer Chemoprevention

Volume 1: Promising Cancer Chemopreventive Agents

  • Book
  • © 2004

Overview

Part of the book series: Cancer Drug Discovery and Development (CDD&D)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (43 chapters)

  1. Antimutagens

  2. Antiinflammatories

  3. Nuclear Receptor Superfamily

    1. Antiandrogens

    2. Antiestrogens

Keywords

About this book

Much progress has been made in discovering and developing agents that have promise, or have already been successfully used, to treat precancerous conditions or inhibit carcinogenesis. In Cancer Chemoprevention, Volume 1: Promising Cancer Chemopreventive Agents, leading researchers in the discovery and development of chemopreventives comprehensively survey all aspects of these emerging therapeutics. For each agent, the authors review the relevant mechanisms of action, the criteria for populations benefiting from intervention, the safety and pharmacodynamics, clinical study design emphasizing the use of precancers, and early associated cellular and molecular biomarkers of carcinogenesis. The pharmacologic and/or mechanistic classes discussed range from antimutagens, antiinflammatories, and the nuclear receptor superfamily, to signal transduction modulators, antioxidants, vitamins, and minerals. The classes vary widely in terms of their stages of development as chemopreventives and include both extensively studied groups and those with recently identified potential based on such mechanistic data as protein kinase inhibition. Attention is also devoted to nutriceuticals (food-derived agents) because of their high promise for prevention in healthy populations. The overall focus is on molecular targets and mechanisms. A second volume, Strategies for Cancer Chemoprevention, describes the exciting methodologies that are accelerating progress in this field and discusses the state of clinical development of chemoprevention in the various human cancer target organs.
Up-to-date and highly practical, Cancer Chemoprevention, Volumes 1 & 2, offer oncologists, pharmacologists, medicinal chemists, and toxicologists a comprehensive reference survey on the identification of promising cancer chemopreventive agents that will help stimulate further research and the development of novel approvable drugs.

Reviews

"...a comprehensive review of seizures...a wealth of information." - British Journal of Anesthesiology

"...a valuable addition to any library in a lboratory researching/developing oncology products..." - BTS Newsletter

"...provides a comprehensive reference survey for basic researchers, pharmacologists and clinical oncologists...a must for everyone involved in chemoprevention research." - Annals of Oncology

Editors and Affiliations

  • National Institutes of Health, Rockville, USA

    Gary J. Kelloff, Ernest T. Hawk

  • CCS Associates, Mountain View, USA

    Caroline C. Sigman

Bibliographic Information

  • Book Title: Cancer Chemoprevention

  • Book Subtitle: Volume 1: Promising Cancer Chemopreventive Agents

  • Editors: Gary J. Kelloff, Ernest T. Hawk, Caroline C. Sigman

  • Series Title: Cancer Drug Discovery and Development

  • DOI: https://doi.org/10.1007/978-1-59259-767-3

  • Publisher: Humana Totowa, NJ

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media New York 2004

  • Hardcover ISBN: 978-1-58829-076-2Published: 04 June 2004

  • Softcover ISBN: 978-1-61737-342-8Published: 19 November 2010

  • eBook ISBN: 978-1-59259-767-3Published: 04 June 2004

  • Series ISSN: 2196-9906

  • Series E-ISSN: 2196-9914

  • Edition Number: 1

  • Number of Pages: XVI, 697

  • Number of Illustrations: 58 b/w illustrations, 1 illustrations in colour

  • Topics: Oncology

Publish with us